Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Etynodiol diacetate

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
Etynodiol diacetate
Clinical data
Trade namesOvulen, Demulen, others
Other namesEthynodiol diacetate; Norethindrol diacetate; 3β-Hydroxynorethisterone 3β,17β-diacetate;[1] 17α-Ethynylestr-4-ene-3β,17β-diyl diacetate; CB-8080; SC-11800
License data
Pregnancy
category
  • Contraindicated
Routes of
administration
By mouth
Drug classProgestogen;Progestin;Progestogen ester
ATC code
Legal status
Legal status
Identifiers
  • [(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.005.496Edit this at Wikidata
Chemical and physical data
FormulaC24H32O4
Molar mass384.516 g·mol−1
3D model (JSmol)
  • O=C(O[C@@H]4/C=C3\[C@@H]([C@H]2CC[C@]1([C@@H](CC[C@]1(C#C)OC(=O)C)[C@@H]2CC3)C)CC4)C
  • InChI=1S/C24H32O4/c1-5-24(28-16(3)26)13-11-22-21-8-6-17-14-18(27-15(2)25)7-9-19(17)20(21)10-12-23(22,24)4/h1,14,18-22H,6-13H2,2-4H3/t18-,19-,20+,21+,22-,23-,24-/m0/s1
  • Key:ONKUMRGIYFNPJW-KIEAKMPYSA-N

Etynodiol diacetate, orethynodiol diacetate, sold under the brand nameOvulen among others, is aprogestin medication which is used inbirth control pills.[4][5][6] The medication is available only in combination with anestrogen.[7] It is takenby mouth.[8]

Etynodiol diacetate is a progestin, or asyntheticprogestogen, and hence is anagonist of theprogesterone receptor, thebiological target of progestogens likeprogesterone.[9][10] It has weakandrogenic andestrogenic activity and no other importanthormonal activity.[11][12][13] The medication is aprodrug ofnorethisterone in the body, withetynodiol occurring as anintermediate.[9][10][14]

Etynodiol, a related compound, was discovered in 1954, and etynodiol diacetate was introduced for medical use in 1965.[15][16] The combination ethynodiol with mestranol (Ovulen) was approved for medical use in the United States in 1966.[17] The combination ethinylestradiol with ethynodiol (Demulen) was approved for medical use in the United States in 1970.[18]

In 2021, the combination withethinylestradiol was the 276th most commonly prescribed medication in the United States, with more than 800,000 prescriptions.[19][20]

Medical uses

[edit]

Etynodiol diacetate is used in combination with anestrogen such as ethinylestradiol ormestranol incombined oral contraceptives for women for the prevention of pregnancy.[8]

Side effects

[edit]
See also:Norethisterone § Side effects, andProgestin § Side effects

Pharmacology

[edit]
Norethisterone (3-ketoetynodiol), theactive metabolite of etynodiol diacetate.

Etynodiol diacetate is virtually inactive in terms ofaffinity for theprogesterone andandrogen receptors and acts as a rapidly convertedprodrug ofnorethisterone, withetynodiol occurring as anintermediate.[9][10][14] Uponoral administration and duringfirst-pass metabolism in theliver, etynodiol diacetate is rapidly converted byesterases into etynodiol,[14] which is followed byoxygenation of the C3hydroxyl group to produce norethisterone.[10] In addition to its progestogenic activity, etynodiol diacetate has weakandrogenic activity,[11][12] and, unlike most progestins but similarly to norethisterone andnoretynodrel,[21] also has someestrogenic activity.[12][13]

Thepharmacokinetics of etynodiol diacetate have been reviewed.[22]

Relative affinities (%) ofnorethisterone, metabolites, and prodrugs
CompoundTypeaPRTooltip Progesterone receptorARTooltip Androgen receptorERTooltip Estrogen receptorGRTooltip Glucocorticoid receptorMRTooltip Mineralocorticoid receptorSHBGTooltip Sex hormone-binding globulinCBGTooltip Corticosteroid binding globulin
Norethisterone67–751500–10–3160
5α-DihydronorethisteroneMetabolite252700???
3α,5α-TetrahydronorethisteroneMetabolite100–10???
3α,5β-TetrahydronorethisteroneMetabolite?00????
3β,5α-TetrahydronorethisteroneMetabolite100–80???
EthinylestradiolMetabolite15–251–31121–300.180
Norethisterone acetateProdrug205100??
Norethisterone enanthateProdrug???????
NoretynodrelProdrug6020000
EtynodiolProdrug1011–180???
Etynodiol diacetateProdrug10000??
LynestrenolProdrug11300??
Notes: Values are percentages (%). Referenceligands (100%) werepromegestone for thePRTooltip progesterone receptor,metribolone for theARTooltip androgen receptor,estradiol for theERTooltip estrogen receptor,dexamethasone for theGRTooltip glucocorticoid receptor,aldosterone for theMRTooltip mineralocorticoid receptor,dihydrotestosterone forSHBGTooltip sex hormone-binding globulin, andcortisol forCBGTooltip Corticosteroid-binding globulin.Footnotes:a =Active or inactivemetabolite,prodrug, or neither of norethisterone.Sources: See template.

Chemistry

[edit]
See also:List of progestogens,Progestogen ester, andList of progestogen esters

Etynodiol diacetate, also known as 3β-hydroxy-17α-ethynyl-19-nortestosterone 3β,17β-diaceate, 3β-hydroxynorethisterone 3β,17β-diacetate, or 17α-ethynylestr-4-ene-3β,17β-diol 3β,17β-diacetate, is asyntheticestranesteroid and aderivative oftestosterone.[1][5][6] It is specifically a derivative of19-nortestosterone and17α-ethynyltestosterone, or ofnorethisterone (17α-ethynyl-19-nortestosterone), in which the C3ketonegroup has beendehydrogenated into a C3βhydroxyl group andacetateesters have been attached at the C3β and C17β positions.[5][6] Etynodiol diacetate is the 3β,17β-diacetateester ofetynodiol (17α-ethynylestr-4-ene-3β,17β-diol).[5][6]

Synthesis

[edit]
Ethynodiol diacetate synthesis:[23] F. B. Colton,U.S. patent 2,843,609 (1958 toSearle). Prepn of the 3-acetate, 17-acetate, and diacetate: P. D. Klimstra,U.S. patent 3,176,013 (1965 to Searle); see also:[24]

Chemical syntheses of etynodiol diacetate have been published.[22]

Reduction ofnorethisterone (1) affords the 3,17-diol. The 3β-hydroxy compound is the desired product; since reactions at C3 do not show nearly thestereoselectivity as those at C17 by virtue of the relative lack of stereo-directing proximate substituents, the formation of the desired isomer is engendered by use of a bulky reducing agent, lithium tri-tert-butoxyaluminum hydride. Acetylation of the 3β,17β-diol affords etynodiol diacetate (3).[23]

History

[edit]

Etynodiol was firstsynthesized in 1954, viareduction ofnorethisterone, and etynodiol diacetate was introduced for medical use in 1965.[15][16]

Society and culture

[edit]

Generic names

[edit]

Etynodiol diacetate is thegeneric name of the drug (theINNTooltip International Nonproprietary Name of its free alcohol form is etynodiol), while ethynodiol diacetate is itsUSANTooltip United States Adopted Name,BANTooltip British Approved Name, andJANTooltip Japanese Accepted Name.[5][6][7] It is also known by its former developmental code names CB-8080 and SC-11800.[5][6][7]

Brand names

[edit]

Etynodiol diacetate is or has been marketed under brand names including Conova, Continuin, Demulen,[18][25] Femulen, Kelnor,[3][25] Lo-Malmorede,[26] Luteonorm, Luto-Metrodiol, Malmorede,[27] Metrodiol, Ovulen,[17][25] Soluna, Zovia,[2] and others.[5][6][7]

Availability

[edit]

Etynodiol diacetate is marketed in only a few countries, including the United States, Canada, Argentina, and Oman.[7]

References

[edit]
  1. ^abSchindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, et al. (December 2003). "Classification and pharmacology of progestins".Maturitas.46 (Suppl 1):S7 –S16.doi:10.1016/j.maturitas.2003.09.014.PMID 14670641.
  2. ^ab"Zovia 1/35- ethynodiol diacetate and ethinyl estradiol tablets kit".Archived from the original on 28 September 2022. Retrieved20 January 2024.
  3. ^ab"Kelnor 1/35- ethynodiol diacetate and ethinyl estradiol kit".Archived from the original on 29 March 2023. Retrieved20 January 2024.
  4. ^Shoupe D, Haseltine FP (6 December 2012).Contraception. Springer Science & Business Media. pp. 21–.ISBN 978-1-4612-2730-4.
  5. ^abcdefgElks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 522–.ISBN 978-1-4757-2085-3.
  6. ^abcdefgIndex Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. p. 422.ISBN 978-3-88763-075-1. Retrieved30 May 2012.
  7. ^abcde"Etynodiol".Drugs.com. Archived fromthe original on 5 February 2018. Retrieved4 February 2018.
  8. ^abBlum RW (22 October 2013).Adolescent Health Care: Clinical Issues. Elsevier Science. pp. 216–.ISBN 978-1-4832-7738-7.
  9. ^abcHammerstein J (December 1990). "Prodrugs: advantage or disadvantage?".American Journal of Obstetrics and Gynecology.163 (6 Pt 2):2198–2203.doi:10.1016/0002-9378(90)90561-K.PMID 2256526.
  10. ^abcdIARC Working Group on the Evaluation of Carcinogenic Risks to Humans, World Health Organization, International Agency for Research on Cancer (2007).Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 146–.ISBN 978-92-832-1291-1.
  11. ^abTashjian AH, Armstrong EJ (21 July 2011).Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. Lippincott Williams & Wilkins. pp. 523–.ISBN 978-1-4511-1805-6.Archived from the original on 11 January 2023. Retrieved11 October 2016.
  12. ^abcBecker KL (24 April 2001).Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. p. 1004.ISBN 978-0-7817-1750-2. Retrieved30 May 2012.
  13. ^abGoroll AH, Mulley AG (27 January 2009).Primary Care Medicine: Office Evaluation and Management of the Adult Patient. Lippincott Williams & Wilkins. p. 876.ISBN 978-0-7817-7513-7. Retrieved30 May 2012.
  14. ^abcStanczyk FZ (September 2002). "Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception".Reviews in Endocrine & Metabolic Disorders.3 (3):211–224.doi:10.1023/A:1020072325818.PMID 12215716.S2CID 27018468.
  15. ^abPetrow V (1971)."Antifertility agents".Progress in Medicinal Chemistry.8 (2):171–229.doi:10.1016/s0079-6468(08)70130-9.ISBN 9780408703147.PMID 4947236.
  16. ^abWilliam Andrew Publishing (22 October 2013).Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 1516–.ISBN 978-0-8155-1856-3.Archived from the original on 20 January 2024. Retrieved4 February 2018.
  17. ^ab"Ovulen: FDA-Approved Drugs".U.S.Food and Drug Administration (FDA).Archived from the original on 8 December 2022. Retrieved20 January 2024.
  18. ^ab"Demulen: FDA-Approved Drugs".U.S.Food and Drug Administration (FDA).Archived from the original on 10 May 2021. Retrieved20 January 2024.
  19. ^"The Top 300 of 2021".ClinCalc.Archived from the original on 15 January 2024. Retrieved14 January 2024.
  20. ^"Ethinyl Estradiol; Ethynodiol - Drug Usage Statistics".ClinCalc.Archived from the original on 18 January 2024. Retrieved14 January 2024.
  21. ^Runnebaum BC, Rabe T, Kiesel L (6 December 2012).Female Contraception: Update and Trends. Springer Science & Business Media. pp. 36–.ISBN 978-3-642-73790-9.
  22. ^abKonstitution J (27 November 2013)."Eigenschaften der Gestagene".Handbuch der Experimentellen Pharmakologie. Cham: Springer-Verlag. pp. 14–15, 286.ISBN 978-3-642-99941-3.
  23. ^abKlimstra PD, Colton FB (October 1967). "The synthesis of 3beta-hydroxyestr-4-en-17-one and 3beta-hydroxyandrost-4-en-17-one".Steroids.10 (4):411–424.doi:10.1016/0039-128X(67)90119-5.PMID 6064262.
  24. ^Sondheimer F, Klibansky Y (1959). "Synthesis of 3β-hydroxy analogues of steroidal hormones, a biologically active class of compounds".Tetrahedron.5:15–26.doi:10.1016/0040-4020(59)80066-1.
  25. ^abc"Estrogen and Progestin (Oral Contraceptives)".Archived from the original on 18 January 2024. Retrieved20 January 2024.
  26. ^"Lo-Malmorede". Archived fromthe original on 24 March 2021. Retrieved20 January 2024.
  27. ^"Malmorede". Archived fromthe original on 1 October 2023. Retrieved20 January 2024.
Progestogens
(andprogestins)
PRTooltip Progesterone receptoragonists
Antiprogestogens
SPRMsTooltip Selective progesterone receptor modulators
PRTooltip Progesterone receptorantagonists
Androgens
(incl.AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptoragonists
Progonadotropins
Antiandrogens
ARTooltip Androgen receptorantagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
ARTooltip Androgen receptor
Agonists
SARMsTooltip Selective androgen receptor modulator
Antagonists
GPRC6A
Agonists
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
PRTooltip Progesterone receptor
Agonists
Mixed
(SPRMsTooltip Selective progesterone receptor modulators)
Antagonists
mPRTooltip Membrane progesterone receptor
(PAQRTooltip Progestin and adipoQ receptor)
Agonists
Antagonists
Portal:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Etynodiol_diacetate&oldid=1303035584"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp